Current status and perspectives of chimeric antigen receptor modified T cells for cancer treatment
Crossref DOI link: https://doi.org/10.1007/s13238-017-0400-z
Published Online: 2017-05-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wang, Zhenguang
Guo, Yelei
Han, Weidong
License valid from 2017-05-02